| VAXCYTE INC. DL -,001 |
| USA |
| Gesundheit |
| US92243G1085 / A2P6R6 |
| 5VA (Frankfurt) / PCVX (NASDAQ) |
| FRA:5VA, ETR:5VA, 5VA:GR, NASDAQ:PCVX |
| - |
| https://vaxcyte.com/ |
|
Vaxcyte Inc. is a clinical-stage vaccine company focused on developing next-generation vaccines for bacterial infectious diseases. The company uses its proprietary cell-free protein synthesis platform to design and produce optimized protein carriers ..
>Volltext.. |
| 7528.92 Mio. EUR |
| 6319.31 Mio. EUR |
| - |
| -1012.37 Mio. EUR |
| -946.35 Mio. EUR |
| -6.86 EUR |
| 102.65 Mio. EUR |
| 162.89 Mio. EUR |
| -783.6 Mio. EUR |
| 5.48 |
| - |
| -100.5% |
| - |
| - |
| - |
| VAXCYTE |
| 03.10.26 |
|